Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin

Summary

Heparin promotes the antithrombin (AT) inactivation of factors IXa (fIXa) and Xa (fXa) through a conformational activation of the serpin and also by a template mechanism in the presence of physiological levels of Ca²⁺. Recently, it was reported that heparin induces conformational changes in the active-sites of fIXa and fXa, raising the possibility that heparin also modulates the reactivity of these proteases with AT by this mechanism. To test this possibility, we prepared an AT mutant in which four critical heparin-binding residues of the serpin (Arg-45, Arg-46, Lys-114, and Arg-129) were replaced with non-basic residues. This mutant lost its affinity for heparin, but retained its normal reactivity with coagulation proteases. Thus, the high-affinity AT-binding pentasaccharide fragment of heparin had no cofactor effect on the reactivity of the AT mutant with coagulation proteases. Full-length heparinconcentration dependence of the AT inhibition of fIXa and fXa revealed that in contrast to a greater than 4–5 orders of magnitude accelerating effect for heparin on the AT inhibition of fIXa and fXa, heparin exhibits a negligible cofactor effect (<2-fold) on the mutant AT inhibition of these proteases. The same results were obtained for the mutant AT inhibition of thrombin and factor VIIa, however, heparin accelerated the mutant AT inhibition of factor XIa ~10-fold. We conclude that, with the exception of factor XIa, heparin-mediated conformational modulation of the active-sites of coagulation proteases makes a minor contribution to the regulation of these proteases by AT.

Keywords

Antithrombin - heparin - coagulation - factor Xa - factor IXa - thrombin

• References

• 1 Olson ST, Björk I. Regulation of thrombin by antithrombin and heparin cofactor II. In Thrombin: Structure and Function. Berliner L. J.. editor. Plenum Press; New York: 1992. pp. 159-217.
• 2 Gettins PGW. Serpins structure, mechanism, and function. Chem Rev 2002; 102: 4751-4803.
• 3 Damus PS, Hicks M, Rosenberg RD. Anticoagulant action of heparin. Nature 1973; 246: 355-357.
• 4 Marcum JA, Rosenberg RD. Anticoagulantly active heparin-like molecules from the vascular tissue. Biochemistry 1984; 23: 1730-1737.
• 5 Carrell RW, Skinner R, Jin L. et al. Structural Mobility of Antithrombin and its Modulation by Heparin. Thromb Haemost 1997; 78: 516-519.
• 6 Weitz JI. Emerging anticoagulants for treatment of venous thromboembolism. Thromb Haemost 2006; 96: 274-284.
• 7 Becattini C, Agnelli G, Emmerich J. et al. Initial treatment of venous thromboembolism. Thromb Haemost 2006; 96: 242-250.
• 8 Olson ST, Swanson R, Raub-Segall E. et al. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. Thromb Haemost 2004; 92: 929-939.
• 9 Huntington JA, McCoy A, Belzar KJ. et al. The conformational activation of antithrombin. J Biol Chem 2000; 275: 15377-15383.
• 10 Johnson DJD, Li W, Adams TE. et al. Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J 2006; 25: 2029-2037.
• 11 Rezaie AR. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla-domain antagonism of heparin binding to factor Xa. J Biol Chem 1998; 273: 16824-16827.
• 12 Yang L, Manithody C, Rezaie AR. Localization of the heparin binding exosite of factor IXa. J Biol Chem 2002; 277: 50756-50760.
• 13 Rao LV, Rapaport SI, Hoang AD. Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Blood 1993; 81: 2600-2607.
• 14 Lawson JH, Butenas S, Ribarik N. et al. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem 1993; 268: 767-770.
• 15 Neuenschwander PF. Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa. Biochemistry 2004; 43: 2978-2986.
• 16 O’Brien LA, Stafford AR, Fredenburgh JC. et al. Glycosaminoglycans bind factor Xa in a Ca2+-dependent fashion and modulate its catalytic activity. Biochemistry 2003; 42: 13091-13098.
• 17 Rezaie AR, Yang L. Probing the molecular basis of factor Xa specificity by muta-genesis of the serpin, antithrombin. Biochem Biophys Acta 2001; 1528: 167-176.
• 18 Olson ST, Björk I, Shore JD. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. Methods Enzymol 1993; 222: 525-560.
• 19 Zhao M, Abdel-Razek T, Sun MF. et al. Characterization of a heparin binding site on the heavy chain of factor XI. J Biol Chem 1998; 273: 31153-31159.
• 20 Misenheimer TM, Buyue Y, Sheehan JP. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic Tenase complex: The role of arginine 165 and factor X. Biochemistry 2007; 46: 7886-7895.
• 21 Bedsted T, Swanson R, Chuang Y-J. et al. Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites. Biochemistry 2003; 42: 8143-8152.
• 22 Wiebe EM, Stafford AR, Fredenburgh JC. et al. Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide. J Biol Chem 2003; 278: 35767-35774.
• 23 Rezaie AR, Olson ST. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa binding complex. Demonstration by rapid kinetics studies. Biochemistry 2000; 39: 12083-12090.
• 24 Jin L, Abrahams J, Skinner R. et al. The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci USA 1997; 94: 14683-14688.
• 25 Danielsson A, Raub E, Lindahl U. et al. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem 1986; 261: 15467-15473.
• 26 Yang L, Sun MF, Gailani D. et al. Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor. Biochemistry 2009; 48: 1517-1524.
• 27 Rezaie AR. Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J Biol Chem 2000; 275: 3320-3327.
• 28 Jin J, Pandey P, Babine RE. et al. Crystal structures of the factor XIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions. J Biol Chem 2005; 280: 4704-4712.
• 29 Dang QD, Di Cera E. Residue 225 determines the Na+-induced allosteric regulation of catalytic activity in serine proteases. Proc Natl Acad Sci USA 1996; 93: 10653-10656.